|
PRKACA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.24749999999663E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.5497399999953E-05 |
| Normal-vs-Stage2 |
6.216900E-04 |
| Normal-vs-Stage3 |
2.522200E-01 |
| Normal-vs-Stage4 |
1.135240E-01 |
| Stage1-vs-Stage2 |
9.396200E-01 |
| Stage1-vs-Stage3 |
5.685600E-02 |
| Stage1-vs-Stage4 |
8.518800E-01 |
| Stage2-vs-Stage3 |
1.207360E-01 |
| Stage2-vs-Stage4 |
9.214000E-01 |
| Stage3-vs-Stage4 |
2.562600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.78490000002363E-06 |
| Normal-vs-AfricanAmerican |
4.204900E-03 |
| Normal-vs-Asian |
3.885600E-01 |
| Caucasian-vs-AfricanAmerican |
1.611780E-01 |
| Caucasian-vs-Asian |
6.351800E-01 |
| AfricanAmerican-vs-Asian |
9.975400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.21490000018987E-07 |
| Normal-vs-Female |
1.380380E-01 |
| Male-vs-Female |
7.843200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.211800E-04 |
| Normal-vs-Extreme_Weight |
1.87460000000694E-06 |
| Normal-vs-Obese |
7.866100E-02 |
| Normal-vs-Extreme_Obese |
8.004500E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.668400E-01 |
| Normal_Weight-vs-Obese |
7.714100E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.056400E-01 |
| Extreme_Weight-vs-Obese |
3.952100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.410600E-01 |
| Obese-vs-Extreme_Obese |
7.805000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.795600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.124780E-03 |
| Normal-vs-Age(61-80Yrs) |
7.35109999983052E-07 |
| Normal-vs-Age(81-100Yrs) |
1.550470E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.316300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.235700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.644140E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.803800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.300620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.907200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.92049999999866E-05 |
| Normal-VS-Type2 PRCC |
7.49840000091595E-08 |
| Normal-VS-KIRP CIMP |
8.387200E-01 |
| Normal-VS-Unclassified PRCC |
3.781400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.837920E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.534960E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.367900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.663300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.217500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.036200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.011500E-04 |
| Normal-vs-N1 |
7.969800E-02 |
| Normal-vs-N2 |
8.663400E-01 |
| N0-vs-N1 |
4.264000E-01 |
| N0-vs-N2 |
6.256800E-01 |
| N1-vs-N2 |
6.582800E-01 |
|
|
